Iowa's harvest season isn't confined to corn and soybean fields this year. MedPharm Iowa has completed its first harvest of Iowa-grown cannabis and has begun producing medical cannabis products.

During a press briefing today, MedPharm General Manager Lucas Nelson said the company is on track to begin distributing those medical products for sales in Iowa, which by law can begin Dec. 1.

Des Moines-based MedPharm is the state’s only authorized manufacturer of cannabidiol products under the Medical Cannabidiol Act enacted by the Legislature in May 2017. The company grows the cannabis in greenhouses next to its 14,000-square-foot facility and completes all of the production, quality testing and packaging entirely on-site at the facility.

MedPharm will distribute its Aliviar brand of capsules, tinctures and creams to five dispensaries in the state, including dispensaries owned and operated by MedPharm in Windsor Heights and Sioux City. Stephen Wilson, who will run both of those dispensaries, said he is confident that MedPharm's production will keep pace with demand at all five dispensaries.  

Nelson said about 1,000 Iowans have been certified or have applied for state certification to purchase medical cannabis products for 10 qualifying conditions, among them cancer, multiple sclerosis and untreatable pain. The company has conducted 11 public awareness events across the state in recent months, and in that process has identified about 200 additional potential patients who could benefit from the products, he said.

A bottle of capsules will retail for $30 to $130 for a 30-day supply, depending on the formulation. More information about the products is available here.